2018
October 18, 2018
LogicBio Therapeutics Announces Pricing of Initial Public Offering
May 23, 2018
LogicBio Therapeutics Appoints Dean Falb, Ph.D., as Chief Scientific Officer
May 14, 2018
LogicBio Therapeutics to Present Data on GeneRide™ Platform Technology
May 9, 2018
LogicBio Therapeutics Launches Development Program in Methylmalonic Acidemia (MMA)
May 2, 2018
LogicBio Therapeutics Strengthens Leadership Team with Key Appointments
January 2, 2018
LogicBio Therapeutics Announces Expansion of Leadership Team through Multiple Key Hires
2017
October 16, 2017
June 27, 2017